HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Steinberg, S. F. Search for Related Content PubMed PubMed Citation Articles by Steinberg, S. F.

Structural Basis of Protein Kinase C Isoform Function

Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York

Protein kinase C (PKC) isoforms comprise a family of lipid-activated enzymes that have been implicated in a wide range of cellular functions. PKCs are modular enzymes comprised of a regulatory domain (that contains the membrane-targeting motifs that respond to lipid cofactors, and in the case of some PKCs calcium) and a relatively conserved catalytic domain that binds ATP and substrates. These enzymes are coexpressed and respond to similar stimulatory agonists in many cell types. However, there is growing evidence that individual PKC isoforms subserve unique (and in some cases opposing) functions in cells, at least in part as a result of isoform-specific subcellular compartmentalization patterns, protein-protein interactions, and posttranslational modifications that influence catalytic function. This review focuses on the structural basis for differences in lipid cofactor responsiveness for individual PKC isoforms, the regulatory phosphorylations that control the normal maturation, activation, signaling function, and downregulation of these enzymes, and the intra-/intermolecular interactions that control PKC isoform activation and subcellular targeting in cells. A detailed understanding of the unique molecular features that underlie isoform-specific posttranslational modification patterns, protein-protein interactions, and subcellular targeting (i.e., that impart functional specificity) should provide the basis for the design of novel PKC isoform-specific activator or inhibitor compounds that can achieve therapeutically useful changes in PKC signaling in cells.

This article has been cited by other articles:

				T. H. Pedersen, W. A. Macdonald, F. V. de Paoli, I. S. Gurung, and O. B. Nielsen Comparison of regulated passive membrane conductance in action potential-firing fast- and slow-twitch muscle J. Gen. Physiol., October 1, 2009; 134(4): 323 - 337. [Abstract] [Full Text] [PDF]

				R. A. Fenton, S. Komatsu, M. Ikebe, L. G. Shea, and J. G. Dobson Jr. Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-{varepsilon} to RACK2 in adult rat and mouse Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H718 - H725. [Abstract] [Full Text] [PDF]

				Q. Liu, X. Chen, S. M. MacDonnell, E. G. Kranias, J. N. Lorenz, M. Leitges, S. R. Houser, and J. D. Molkentin Protein Kinase C{alpha}, but Not PKC{beta} or PKC{gamma}, Regulates Contractility and Heart Failure Susceptibility: Implications for Ruboxistaurin as a Novel Therapeutic Approach Circ. Res., July 17, 2009; 105(2): 194 - 200. [Abstract] [Full Text] [PDF]

				K. Chang, D. Xiao, X. Huang, L. D. Longo, and L. Zhang Chronic hypoxia increases pressure-dependent myogenic tone of the uterine artery in pregnant sheep: role of ERK/PKC pathway Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1840 - H1849. [Abstract] [Full Text] [PDF]